Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allelic loss at TP53 in metastatic human endometrial carcinomas.

Clinical & experimental metastasis - 1 Jan 2009

Szewczuk Wiktor, Skomra Danuta, Cybulski Marek, Przadka-Rabaniuk Dorota, Filip Agata, Jóźwik Maciej, Olcha Piotr, Roessner Albert, Semczuk Andrzej

Abstract excerpt

Loss of heterozygosity (LOH) is implicated in the initiation and progression of various human neoplasia, and is observed in both early or in advanced-stage human cancers. The current study was aimed at investigating the frequency of LOH TP53 in human endometrial carcinoma (EC) metastases. LOH was analyzed using 3 intragenic polymorphisms in 38 primary ECs and corresponding metastatic lesions. Allelic loss at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alleles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Genes, p53

Share to Immunohistochemistry

Share to Introns

Share to Loss of Heterozygosity

Share to Neoplasm Metastasis

Source

Identifiers

PMID: 19565339
DOI: 10.1007/s10585-009-9278-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allelic loss at TP53 in metastatic human endometrial carcinomas.PMID 19565339Read ↗

Prevalence of allelic loss at TP53 in endometrial carcinomas.Semantic proximity Read ↗

Clinical and biological characteristics associated with loss-of-heterozygosity in endometrial cancer.Semantic proximity Read ↗

Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients.Semantic proximity Read ↗

Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometriumSemantic proximity Read ↗

Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the <i>TP53</i> geneSemantic proximity Read ↗

A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model.Semantic proximity Read ↗

Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.Semantic proximity Read ↗

p53 gene mutations in human endometrial carcinoma.Semantic proximity Read ↗

Allelotype of endometrial carcinoma.Semantic proximity Read ↗

Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.Semantic proximity Read ↗

Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.Semantic proximity Read ↗

Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.